BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T113000
DTSTAMP:20260410T132438
CREATED:20200327T100140Z
LAST-MODIFIED:20200327T100140Z
UID:18108-1601546400-1601551800@staging.medilinkmidlands.com
SUMMARY:Webinar: Commercial Applications for Next Generation Biomaterials
DESCRIPTION:This webinar with the University of Nottingham will look at Commercial Applications for Next Generation Biomaterials. \nThe biomaterials discovery programme at the University of Nottingham has been targeting novel polymers with application as coatings for existing medical devices to reduce infection rates and controlling foreign body reaction\, cell culture consumables for expansion and differentiation of stem cells\, particulates for targeting therapeutic delivery for cancer and infections and surfaces to control viral\, fungal and bacterial attachment in a wide variety of industries. They are looking for industrial organisations to partner with in the exploitation of these materials. \nPresentations will include: \n– Controlling bacterial biofilms formation using polymers \n– Controlling foreign body reaction to medical implants using coatings \n– New materials for breast cancer therapies \n– Technologies to control Fibrosis \nThere will be a Q&A session during the webinar. We have also created a facility post event (11.30am – 12.00pm) for you to join the presenters in a Microsoft Teams meeting to ask further questions directly to the presenters. Details of this meeting will be shared during the webinar. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nThe Biomaterials Discovery project at the University of Nottingham has funding available to partner with industrial partners that are keen to explore its emerging novel biomaterials and their potential in healthcare in short proof of concept studies. They encourage any companies that can see application of these technologies in their area to contact the panellists in the discussion session or send us an email. Please click here to contact the team. \n  \nSPEAKER PROFILES: \n \nProfessor Morgan Alexander\, Professor of Biomedical Surfaces\, University of Nottingham \nMorgan Alexander is Professor of Biomedical Surfaces\, the Director of the EPSRC Programme Grant in Next Generation Biomaterials Discovery and a Wellcome Trust Senior Investigator based in the School of Pharmacy at the University of Nottingham. He received his BSc in Materials (1988) and his PhD from the same department at The University of Sheffield in 1992. \nHis work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of next generation biomaterials and it is the theme running through his group’s work across a variety of areas spanning control of bacterial adhesion\, to engineering cell response with applications in medical devices and cell manufacture. \n \nKiril Kalenderski\, PhD Student\, University of Nottingham \nKiril is a researcher at the University of Nottingham\, studying biofilm formation on bio-material surfaces developed as medical device coatings. He has predominantly worked with indwelling urinary catheters\, to determine the efficacy of bio-material coatings in reducing biofilm formation on these devices\, within in vitro experiments and clinical settings. \n  \n  \nDr Robert Cavanagh\, Research Fellow\, University of Nottingham \nRob completed his PhD in Drug delivery in 2017 at the University of Nottingham and focused on investigating intestinal permeability enhancers for the delivery of biologics. He joined Professor Cameron Alexander’s group in December 2017 as a post-doctoral researcher studying chemotherapeutic delivery using novel polymeric nanoparticles. \n  \n  \nDr Patrícia Monteiro\, Research Fellow\, University of Nottingham \nPatrícia received a B.Sc. and M.Sc. in Pharmacy and Pharmaceutical Sciences from the Federal University of Ouro Preto (UFOP)\, Brazil. In 2019 she completed her Ph.D. in drug delivery at the University of Nottingham. She then joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher. Her current research is focused on the development of bioresponsive polymers for triple negative breast cancer therapy. \n  \n  \n  \nDr Leanne Fisher\, Research Fellow\, University of Nottingham \nSchool of Life Sciences\, Immunology and Immuno-bioengineering Group \nLeanne’s research has focussed on the design and development of antimicrobial/anti-fouling surfaces to prevent the formation of biofilms on medical devices. More recently\, she has been studying the impact of surface engineering on immune modulation and prevention of the foreign body response. Alongside this\, Leanne works in developing immune-competent biomimetic tissue models\, specifically organ-on-a-chip models. \n  \n \nDr Matthew Vassey\, Research Fellow\, University of Nottingham \nMatthew received a B.Sc. in Microbiology and Cellular Biology in 2005 at the University of Nottingham. In 2014 he completed his Ph.D. in Cellular Microbiology also at the University of Nottingham. He joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher in November 2017. His current research is focused on cell biology\, human iPSC derived cells\, 3D biology\, host-pathogen interactions and infection biology. \n  \n  \n \nArsalan Latif\, PhD Student\, University of Nottingham \nArsalan is a final year doctoral student researching in developing stromal instructive niches to promote healing and suppress fibrosis\, at the University of Nottingham. Before which he did his master’s in biomedical engineering at Chalmers University of Technology\, Sweden. Besides science\, he enjoys building Lego models in his spare time. \n 
URL:https://staging.medilinkmidlands.com/event/commercial-applications-for-next-generation-biomaterials/
CATEGORIES:Project Event
ATTACH;FMTTYPE=image/jpeg:https://staging.medilinkmidlands.com/wp-content/uploads/2022/04/Morgan-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR